For instance, a woman living with HIV could choose not to go back for more medication because she's scared someone from her community will see her and learn her status
"Our method addresses this problem by designing a vaccine component that mimics a protein-sugar part of this shield," said Wang.
Sex workers and their clients, gay men, people who inject drugs, transgenders largely affected
The HIV Vaccine Trials Network (HVTN) is conducting the trial at 15 sites across South Africa. Results are expected in late 2020
An emerging vaccine strategy involves immunising people with a series of different engineered HIV proteins as immunogens
The country has the 3rd largest number of people living with HIV in the world.